Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-163386
Filing Date
2017-05-09
Accepted
2017-05-09 07:18:54
Documents
62
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d354507d10q.htm 10-Q 323799
2 EX-10.1 d354507dex101.htm EX-10.1 21625
3 EX-31.1 d354507dex311.htm EX-31.1 6288
4 EX-31.2 d354507dex312.htm EX-31.2 6282
5 EX-32.1 d354507dex321.htm EX-32.1 3650
6 EX-32.2 d354507dex322.htm EX-32.2 3644
  Complete submission text file 0001193125-17-163386.txt   2866072

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT srra-20170331.xml EX-101.INS 490467
8 XBRL TAXONOMY EXTENSION SCHEMA srra-20170331.xsd EX-101.SCH 37501
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20170331_cal.xml EX-101.CAL 47581
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20170331_def.xml EX-101.DEF 126052
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20170331_lab.xml EX-101.LAB 328023
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20170331_pre.xml EX-101.PRE 225331
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37490 | Film No.: 17824418
SIC: 2834 Pharmaceutical Preparations